Non-alcoholic fatty liver disease (NAFLD), a further expression of metabolic syndrome,
strictly linked to obesity and diabetes mellitus, is characterized by insulin resistance (IR) …

Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of clinicopathologic
conditions ranging from steatosis alone to nonalcoholic steatohepatitis (NASH), with varying …

Non-alcoholic fatty liver disease (NAFLD), the major cause of abnormal liver function in the
western world, is often associated with obesity and diabetes. In obese individuals, fat …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized pathology with a
high prevalence and a possible evolution to its inflammatory counterpart (non-alcoholic …

Non-alcoholic fatty liver disease (NAFLD) is in parallel with the obesity epidemic and it is the
most common cause of liver diseases. The development of hepatic steatosis in majority of …

Obesity is characterized by the deposition of excessive body fat, and is caused by energy
imbalance, especially when consuming fat-rich diets. High fat diet (HFD)-associated obesity …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common etiologies of chronic
liver disease worldwide. NALFD encompasses a continuum of histological findings ranging …

Nonalcoholic fatty liver disease (NAFLD) is a new challenge in modern medicine, due to its
high prevalence in the world. The pathogenesis of NAFLD is a complex dysmetabolic …

Non-alcoholic fatty liver disease (NAFLD) is often associated with features of the metabolic
syndrome, carrying an increased risk to develop non-alcoholic steatohepatitis (NASH), the …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver-related
morbidity and mortality. It can develop secondary to numerous causes but a great majority of …